Regulatory Correspondence
Regulatory correspondence refers to written communications exchanged between an organization and a regulatory authority, or communications an organization distributes that fall under regulatory rules. These exchanges often document questions, commitments, and expectations, and can later become the basis for audit inquiries. Because such records can carry compliance significance, organizations frequently track and manage them carefully.
Regulatory correspondence encompasses written communications (including electronic) that are subject to regulatory requirements or exchanged with a supervisory authority, though its precise meaning is context- and jurisdiction-specific. In some securities contexts, 'correspondence' is defined narrowly by reference to distribution thresholds; for example, one exhibit filed in connection with a self-regulatory organization rule defines 'correspondence' as any written (including electronic) communication distributed or made available to 25 or fewer retail investors within a 30-day period. In the pharmaceutical sector, the term commonly denotes 'controlled correspondence,' a structured route of communication between the FDA and the generic-drug industry used to facilitate generic-drug development, governed by applicable FDA guidance. Practitioners often treat correspondence as a control-relevant record because it can establish regulatory expectations and commitments and serve as a starting point for audit questions; effective tracking and management are widely regarded as leading practice rather than a single uniform obligation. Applicability, definitions, and thresholds vary by regulator, sector, and jurisdiction, and specific requirements should be verified against the governing primary source.
Why it matters
Regulatory correspondence often functions as a durable record of the specific expectations a regulator has communicated and the commitments an organization has made in return. Because these written exchanges can establish where regulatory expectations are set and where commitments are documented, they frequently become the starting point for later audit questions and supervisory inquiries. Treating correspondence casually can therefore create compliance exposure that only becomes apparent when a regulator revisits an earlier exchange.
The stakes are heightened by the fact that correspondence records are commonly relied upon during examinations and audits. Where such records are misplaced or poorly tracked, an organization may struggle to demonstrate what was asked, what was promised, and what was ultimately done, which can complicate its ability to evidence compliance. For this reason, a well-organized tracking system is often described as a team's best defense against these challenges, particularly in heavily regulated sectors such as pharmaceuticals.
It is important to note that the significance and precise definition of regulatory correspondence vary by regulator, sector, and jurisdiction. In some securities contexts the term is defined narrowly by reference to distribution thresholds, while in the pharmaceutical sector it commonly refers to a structured 'controlled correspondence' channel. Organizations should confirm which meaning and requirements apply to their circumstances against the governing primary source, as robust tracking is widely regarded as leading practice rather than a single uniform legal obligation.
Who it's relevant to
Inside Regulatory Correspondence
Common questions
Answers to the questions practitioners most commonly ask about Regulatory Correspondence.
